MO‐G‐137‐05: Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters

M. Taylor, Z. Liao, J. Bluett, M. Kerr, Heng Li, N. Sahoo, M. Gillin, X. Zhu, X. Zhang

Research output: Contribution to journalArticle

Abstract

Purpose: To demonstrate the importance of optimizing compensator parameters in passive scattering proton therapy (PSPT). Method:We examined the plans of four patients treated for lung tumors at MD Anderson Cancer Center. Comparable IMRT and PSPT plans had been created for each of these patients. The clinical PSPT plans were calculated using 5 mm drill bit compensators with smearing values of 0.5 to 0.9 cm. Two new plans were created for each patient: one with a smearing value of 0 cm and a second with 0 cm smearing and smooth compensators. The prescribed isodose line of each plan was changed so that PTV D95 was equal in a given patient's plans and robustness analysis was performed to evaluate the impact of the compensator changes. A plan was considered robust if ITV D95 remained greater than 95% of the prescribed dose in the worst case scenario for target coverage. The robust plan with altered compensator parameters and most improved normal tissue sparing was considered to be the compensator optimized plan. Results: Mean lung dose for the 4 patients is 19.8, 12.7, 11.9 and 12.4 Gy in the compensator optimized plans compared to 21.8, 14.2, 12.9 and 13.6 Gy in the clinical plans; esophagus V60 is 39.2%, 13.4%, 7.7% and 17.7% compared to 48.6%, 18.1%, 11.6% and 20.7%; mean heart dose is 23.3, 1.2, 8.2 and 4.6 Gy compared to 24.7, 2.4, 9.5 and 8.3 Gy. Conclusion: Robustness analysis allows reduction of the smearing parameter while keeping confidence that the plan is robust against range and setup uncertainties. Compensator parameters should be individually optimized if PSPT plans are to display maximum advantage over IMRT plans in terms of dose volume data.

Original languageEnglish (US)
Pages (from-to)416-417
Number of pages2
JournalMedical physics
Volume40
Issue number6
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Proton Therapy
Lung
Mandrillus
Esophagus
Uncertainty
Neoplasms

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

MO‐G‐137‐05 : Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters. / Taylor, M.; Liao, Z.; Bluett, J.; Kerr, M.; Li, Heng; Sahoo, N.; Gillin, M.; Zhu, X.; Zhang, X.

In: Medical physics, Vol. 40, No. 6, 01.01.2013, p. 416-417.

Research output: Contribution to journalArticle

Taylor, M, Liao, Z, Bluett, J, Kerr, M, Li, H, Sahoo, N, Gillin, M, Zhu, X & Zhang, X 2013, 'MO‐G‐137‐05: Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters', Medical physics, vol. 40, no. 6, pp. 416-417. https://doi.org/10.1118/1.4815318
Taylor, M. ; Liao, Z. ; Bluett, J. ; Kerr, M. ; Li, Heng ; Sahoo, N. ; Gillin, M. ; Zhu, X. ; Zhang, X. / MO‐G‐137‐05 : Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters. In: Medical physics. 2013 ; Vol. 40, No. 6. pp. 416-417.
@article{f6dbec89f8ab4d3cbc30a1f4d05dc879,
title = "MO‐G‐137‐05: Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters",
abstract = "Purpose: To demonstrate the importance of optimizing compensator parameters in passive scattering proton therapy (PSPT). Method:We examined the plans of four patients treated for lung tumors at MD Anderson Cancer Center. Comparable IMRT and PSPT plans had been created for each of these patients. The clinical PSPT plans were calculated using 5 mm drill bit compensators with smearing values of 0.5 to 0.9 cm. Two new plans were created for each patient: one with a smearing value of 0 cm and a second with 0 cm smearing and smooth compensators. The prescribed isodose line of each plan was changed so that PTV D95 was equal in a given patient's plans and robustness analysis was performed to evaluate the impact of the compensator changes. A plan was considered robust if ITV D95 remained greater than 95{\%} of the prescribed dose in the worst case scenario for target coverage. The robust plan with altered compensator parameters and most improved normal tissue sparing was considered to be the compensator optimized plan. Results: Mean lung dose for the 4 patients is 19.8, 12.7, 11.9 and 12.4 Gy in the compensator optimized plans compared to 21.8, 14.2, 12.9 and 13.6 Gy in the clinical plans; esophagus V60 is 39.2{\%}, 13.4{\%}, 7.7{\%} and 17.7{\%} compared to 48.6{\%}, 18.1{\%}, 11.6{\%} and 20.7{\%}; mean heart dose is 23.3, 1.2, 8.2 and 4.6 Gy compared to 24.7, 2.4, 9.5 and 8.3 Gy. Conclusion: Robustness analysis allows reduction of the smearing parameter while keeping confidence that the plan is robust against range and setup uncertainties. Compensator parameters should be individually optimized if PSPT plans are to display maximum advantage over IMRT plans in terms of dose volume data.",
author = "M. Taylor and Z. Liao and J. Bluett and M. Kerr and Heng Li and N. Sahoo and M. Gillin and X. Zhu and X. Zhang",
year = "2013",
month = "1",
day = "1",
doi = "10.1118/1.4815318",
language = "English (US)",
volume = "40",
pages = "416--417",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐G‐137‐05

T2 - Improving Passive Scattering Proton Therapy Plan Quality by Optimizing Compensator Parameters

AU - Taylor, M.

AU - Liao, Z.

AU - Bluett, J.

AU - Kerr, M.

AU - Li, Heng

AU - Sahoo, N.

AU - Gillin, M.

AU - Zhu, X.

AU - Zhang, X.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Purpose: To demonstrate the importance of optimizing compensator parameters in passive scattering proton therapy (PSPT). Method:We examined the plans of four patients treated for lung tumors at MD Anderson Cancer Center. Comparable IMRT and PSPT plans had been created for each of these patients. The clinical PSPT plans were calculated using 5 mm drill bit compensators with smearing values of 0.5 to 0.9 cm. Two new plans were created for each patient: one with a smearing value of 0 cm and a second with 0 cm smearing and smooth compensators. The prescribed isodose line of each plan was changed so that PTV D95 was equal in a given patient's plans and robustness analysis was performed to evaluate the impact of the compensator changes. A plan was considered robust if ITV D95 remained greater than 95% of the prescribed dose in the worst case scenario for target coverage. The robust plan with altered compensator parameters and most improved normal tissue sparing was considered to be the compensator optimized plan. Results: Mean lung dose for the 4 patients is 19.8, 12.7, 11.9 and 12.4 Gy in the compensator optimized plans compared to 21.8, 14.2, 12.9 and 13.6 Gy in the clinical plans; esophagus V60 is 39.2%, 13.4%, 7.7% and 17.7% compared to 48.6%, 18.1%, 11.6% and 20.7%; mean heart dose is 23.3, 1.2, 8.2 and 4.6 Gy compared to 24.7, 2.4, 9.5 and 8.3 Gy. Conclusion: Robustness analysis allows reduction of the smearing parameter while keeping confidence that the plan is robust against range and setup uncertainties. Compensator parameters should be individually optimized if PSPT plans are to display maximum advantage over IMRT plans in terms of dose volume data.

AB - Purpose: To demonstrate the importance of optimizing compensator parameters in passive scattering proton therapy (PSPT). Method:We examined the plans of four patients treated for lung tumors at MD Anderson Cancer Center. Comparable IMRT and PSPT plans had been created for each of these patients. The clinical PSPT plans were calculated using 5 mm drill bit compensators with smearing values of 0.5 to 0.9 cm. Two new plans were created for each patient: one with a smearing value of 0 cm and a second with 0 cm smearing and smooth compensators. The prescribed isodose line of each plan was changed so that PTV D95 was equal in a given patient's plans and robustness analysis was performed to evaluate the impact of the compensator changes. A plan was considered robust if ITV D95 remained greater than 95% of the prescribed dose in the worst case scenario for target coverage. The robust plan with altered compensator parameters and most improved normal tissue sparing was considered to be the compensator optimized plan. Results: Mean lung dose for the 4 patients is 19.8, 12.7, 11.9 and 12.4 Gy in the compensator optimized plans compared to 21.8, 14.2, 12.9 and 13.6 Gy in the clinical plans; esophagus V60 is 39.2%, 13.4%, 7.7% and 17.7% compared to 48.6%, 18.1%, 11.6% and 20.7%; mean heart dose is 23.3, 1.2, 8.2 and 4.6 Gy compared to 24.7, 2.4, 9.5 and 8.3 Gy. Conclusion: Robustness analysis allows reduction of the smearing parameter while keeping confidence that the plan is robust against range and setup uncertainties. Compensator parameters should be individually optimized if PSPT plans are to display maximum advantage over IMRT plans in terms of dose volume data.

UR - http://www.scopus.com/inward/record.url?scp=85024778716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024778716&partnerID=8YFLogxK

U2 - 10.1118/1.4815318

DO - 10.1118/1.4815318

M3 - Article

AN - SCOPUS:85024778716

VL - 40

SP - 416

EP - 417

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -